Enrico Fazzini

Last updated
Enrico Fazzini
Nationality American
Education Boston University
University of Osteopathic Medicine and Health Sciences
OccupationPhysician

Enrico Fazzini is an American neurologist. He is considered an expert on Parkinson's disease and has published numerous research publications on the subject. He has been involved in a number of clinical trials for new pharmaceutical treatments for Parkinson's disease. He attended the University of Osteopathic Medicine and Health Sciences in Des Moines, Iowa. [1] He is board certified in neurology by both the M.D. and D.O. medical boards. [2] He began his practice in 1989. Dr. Enrico Fazzini completed his neurology training at Boston University in 1987 and his fellowship in Movement Disorders at Columbia Presbyterian in 1989. [2] In addition to being a neurologist, Fazzini has a Ph.D. in Behavioral Neuroscience from Boston University and is an expert on the diagnosis and treatment of patients with traumatic brain injuries.[ citation needed ]

Contents

Publications

Fazzini's publications are listed on PubMed. [3] Fazzini is credited[ by whom? ] with reintroducing surgical therapies utilized in the treatment of Parkinson's disease.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Neurology</span> Medical specialty dealing with disorders of the nervous system

Neurology is the branch of medicine dealing with the diagnosis and treatment of all categories of conditions and disease involving the nervous system, which comprises the brain, the spinal cord and the peripheral nerves. Neurological practice relies heavily on the field of neuroscience, the scientific study of the nervous system.

Sidney Gilman is a retired physician, neurologist, and educator. He is an expert on Alzheimer's disease and spent the majority of his career at the University of Michigan, its medical school, and its Health System.

<span class="mw-page-title-main">Encephalitis lethargica</span> Form of encephalitis (sleeping sickness)

Encephalitis lethargica is an atypical form of encephalitis. Also known as "sleeping sickness" or "sleepy sickness", it was first described in 1917 by neurologist Constantin von Economo and pathologist Jean-René Cruchet. The disease attacks the brain, leaving some victims in a statue-like condition, speechless and motionless. Between 1915 and 1926, an epidemic of encephalitis lethargica spread around the world. The exact number of people infected is unknown, but it is estimated that more than one million people contracted the disease during the epidemic, which directly caused more than 500,000 deaths. Most of those who survived never returned to their pre-morbid vigour.

Ablative brain surgery is the surgical ablation by various methods of brain tissue to treat neurological or psychological disorders. The word "Ablation" stems from the Latin word Ablatus meaning "carried away". In most cases, however, ablative brain surgery does not involve removing brain tissue, but rather destroying tissue and leaving it in place. The lesions it causes are irreversible. There are some target nuclei for ablative surgery and deep brain stimulation. Those nuclei are the motor thalamus, the globus pallidus, and the subthalamic nucleus.

Derek Ernest Denny-Brown OBE was a New Zealand-born neurologist. Working in Oxford, London and Boston, he made major contributions to the field of neurology, such as the development of electromyography, physiology of micturition and the treatment of Wilson's disease.

<span class="mw-page-title-main">Bradyphrenia</span> Slow mental activity

Bradyphrenia is the slowness of thought common to many disorders of the brain. Disorders characterized by bradyphrenia include Parkinson's disease and forms of schizophrenia consequently causing a delayed response and fatigue. Patients with bradyphrenia may describe or may manifest slowed thought processes, evidenced by increased latency of response and also involve severe memory impairment and poor motor control. The word 'bradyphrenia' originates from the ancient Greek meaning 'slow mind.'

<span class="mw-page-title-main">Andrew Lees (neurologist)</span> UK neurologist (born 1947)

Andrew John Lees is Professor of Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square, London and University College London. In 2011 he was named as the world's most highly cited Parkinson's disease researcher.

<span class="mw-page-title-main">Moiz Bakhiet</span> Bahrahi-Swedish professor

Moiz Bakhiet is a Swedish - Sudanese Professor. He is the chairman (Founder) of the department of molecular medicine at the Arabian Gulf University and the CEO (Founder) of Princess Al-Jawhara Center for Molecular Medicine, Genetics and Inherited Diseases in the Kingdom of Bahrain. He is also a neurologist at the Bahrain Royal Medical Services, the King Hamad University Hospita and currently King Abdulla Medical City in the Bahraini capital, Manama.

Gregor Karl Wenning is a German neurologist best known for his clinical and scientific work in Parkinson's disease and atypical Parkinsonian disorders, particularly multiple system atrophy (MSA). In 2006 he was appointed Professor and Head of the Division of Clinical Neurobiology at the Medical University Innsbruck.

<span class="mw-page-title-main">Joseph Jankovic</span> American neurologist

Joseph Jankovic is Professor at the Baylor College of Medicine, Houston, Texas in the Department of Neurology. He is also the Founder and Director of the Parkinson's Disease Center and Movement Disorders Clinicat Baylor College of Medicine and holds the Distinguished Chair in Movement Disorders in the same institution.

David Eidelberg is an American neuroscientist who is a professor of Neurology and Molecular Medicine at the Zucker School of Medicine. He is a neuroscientist best known for applying functional imaging of the brain to study neurological diseases.

David Charles is an American neurologist, professor and vice-chair of neurology, and the medical director of Telehealth at Vanderbilt University Medical Center.

<span class="mw-page-title-main">Michael Jeffrey Aminoff</span> American clinical neurologist and neurophysiologist

Michael Jeffrey Aminoff is a clinical neurologist and neurophysiologist whose work currently focuses on treating Parkinson's disease and related movement disorders. He lives in San Francisco, California.

Pasquale Calabrese born 27 February 1961 in Naples, Italy, is an Italian professor of clinical neurosciences at the University of Basel, Faculty of Psychology, Department of Molecular and Cognitive Neurosciences. He is a neuroscientist, experimental neurologist and medical neuropsychologist.

<span class="mw-page-title-main">Henryk Stepien</span> Polish endocrinologist, neurologist and researcher

Henryk Mikołaj Stępień is a Polish endocrinologist, neurologist and professor of medicine who is head of the Department of Endocrinology at the Medical University of Lodz and was rector of the Medical Academy of Lodz from 1996 to 2002.

<span class="mw-page-title-main">Dirk Dressler</span> German neurologist and psychiatrist

Konrad Karl Erich Bodo Wilhelm Dirk Dressler is a German neurologist and psychiatrist. He is Full Professor of Neurology at Hannover Medical School. His research focus is neurological movement disorders and the development and introduction of the botulinum toxin therapy.

Dennis J. Selkoe is an American physician (neurologist) known for his research into the molecular basis of Alzheimer's disease. In 1985 he became Co-Director of the Center for Neurological Diseases and from 1990, Vincent and Stella Coates Professor of Neurological Diseases at Harvard Medical School. He is also a Fellow of the AAAS and a member of the National Academy of Medicine.

Jerrold Lee Vitek is an American neurologist. He is the Head of the Neurology Department, Director of the Neuromodulation Research Program, and Center Director of the University of Minnesota Udall Center of Excellence for Parkinson's Research. Vitek's clinical interests include movement disorders and evaluation for deep brain stimulation (DBS) and his current research activities focus on Parkinson's disease, dystonia, tremor and deep brain stimulation.

Charalampos (Haris) Tzoulis is a Professor of Neurology and Neurogenetics. He is a trained neurologist and co-director of the Neuro-SysMed Center for Clinical Trials Research in neurological diseases, at the University of Bergen and Haukeland University Hospital, funded amongst others by the Norwegian Research Council. In 2022, he established the K.G. Jebsen Center for Translational Research in Parkinson's Disease at the University of Bergen, with funding from the K.G. Jebsen Foundation, focusing on better diagnostics and identification of disease subtypes in order to offer personalized treatments.

Michael S. Okun is an American neurologist, neuroscientist and author. He is the co-founder and director of the Norman Fixel Institute for Neurological Diseases at University of Florida Health and is also the chair of the Department of Neurology at the University of Florida and the Medical Director/Advisor for the Parkinson's Foundation.

References

  1. "Enrico A Fazzini". WebMD. Retrieved 25 August 2012.
  2. 1 2 "Enrico Fazzini, D.O., Ph.D." NYU Langone Medical Center. Retrieved 25 August 2012.
  3. ""Fazzini E"[Author] - PubMed - NCBI". Ncbi.nlm.nih.gov. 2012-05-24. Retrieved 2012-08-24.